
  
    
      
        Background
        Missing outcome data are common in clinical studies [ <NUMEX TYPE="CARDINAL">1</NUMEX>
        <NUMEX TYPE="CARDINAL">2</NUMEX> ] . Many approaches assume missing at random (<ENAMEX TYPE="GPE">MAR</ENAMEX>) as a
        base case. <ENAMEX TYPE="ORGANIZATION">MAR</ENAMEX> means that the probability of missing
        depends only on observed variables [ <ENAMEX TYPE="LAW">3</ENAMEX> ] . <NUMEX TYPE="CARDINAL">Four</NUMEX> strategies
        for examining the bias or sensitivity of results when <ENAMEX TYPE="ORGANIZATION">MAR</ENAMEX>
        does not hold are to ( 
        i ) fit all saturated <ENAMEX TYPE="GPE">MAR</ENAMEX> and non-<ENAMEX TYPE="GPE">MAR</ENAMEX>
        missing-data models [ <NUMEX TYPE="CARDINAL">4 5</NUMEX> ] , ( 
        <ENAMEX TYPE="ORGANIZATION">ii</ENAMEX> ) add a parameter to various <ENAMEX TYPE="ORGANIZATION">MAR</ENAMEX>
        models to make them non-<ENAMEX TYPE="GPE">MAR</ENAMEX> and test if the fit is
        significantly improved [ <NUMEX TYPE="CARDINAL">6 7</NUMEX> ] , ( 
        <ENAMEX TYPE="PERSON">iii</ENAMEX> ) impute the missing data in one
        arm using the observed proportion of events in the other
        arm [ <NUMEX TYPE="CARDINAL">8 9</NUMEX> ] , ( 
        <ENAMEX TYPE="PRODUCT">iv</ENAMEX> ) estimate results under a non-<ENAMEX TYPE="GPE">MAR</ENAMEX>
        missing-data mechanism with key parameters specified by the
        <ENAMEX TYPE="PER_DESC">investigator</ENAMEX> [ <ENAMEX TYPE="LAW">1 10</ENAMEX> ] - [ <TIMEX TYPE="DATE">13</TIMEX> ] . We propose a variation of
        method ( 
        <ENAMEX TYPE="PRODUCT">iv</ENAMEX> ) for randomized trials with
        binary outcome that explicitly uses the randomization
        distribution to reduce user input. To our knowledge this is
        the only method that exploits the randomization
        distribution for missing-data adjustment.
        We illustrate the methodology using data from the Polyp
        <ENAMEX TYPE="ORGANIZATION">Prevention Trial</ENAMEX> (PPT) in which <NUMEX TYPE="CARDINAL">2079</NUMEX> <ENAMEX TYPE="PER_DESC">men</ENAMEX> and <ENAMEX TYPE="PER_DESC">women</ENAMEX> with
        recently removed colorectal adenoma were randomized to
        receive either intensive counseling to adopt a low-fat diet
        (intervention) or a standard brochure on healthy eating
        (control) [ <TIMEX TYPE="DATE">14</TIMEX> ] . The binary outcome was at least one
        adenoma detected on colonoscopy following randomization. In
        the control arm <NUMEX TYPE="PERCENT">9%</NUMEX> of the <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> were missing the
        outcome, and in the intervention arm <NUMEX TYPE="PERCENT">7%</NUMEX> were missing the
        outcome. Dropping the data from <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> with a missing
        outcome gives an estimated difference of -<NUMEX TYPE="CARDINAL">.002</NUMEX> (<ENAMEX TYPE="PERSON">s.e.</ENAMEX>=<NUMEX TYPE="CARDINAL">.022</NUMEX>)
        in the probability of adenoma recurrence between the
        intervention and control <ENAMEX TYPE="ORG_DESC">groups</ENAMEX>. Thus there was very little
        evidence that intensive counseling to adopt a low-fat diet
        reduced the probability of adenoma recurrence. An important
        question was whether or not an adjustment for the missing
        <ENAMEX TYPE="PERSON">outcomes</ENAMEX> would have changed this conclusion.
      
      
        Methods
        
          <ENAMEX TYPE="PERSON">Adjusting for Observed Covariates</ENAMEX>
          As a starting point, we assume the data are missing at
          <ENAMEX TYPE="ORGANIZATION">random</ENAMEX> (<ENAMEX TYPE="GPE">MAR</ENAMEX>). Let 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> denote the binary outcome of
          adenoma recurrence. Let 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX> denote random assignment to
          the control <ENAMEX TYPE="ORG_DESC">group</ENAMEX> and 
          Z = <NUMEX TYPE="CARDINAL">1</NUMEX> denote random assignment to
          the intervention <ENAMEX TYPE="ORG_DESC">group</ENAMEX>. Also let 
          R = <NUMEX TYPE="CARDINAL">0</NUMEX> if the outcome is missing and
          <NUMEX TYPE="CARDINAL">1</NUMEX> if the outcome is observed. Suppose we also have data
          on the observed variable 
          <ENAMEX TYPE="ORGANIZATION">S</ENAMEX> , which represents either strata
          formed by the cross-classification of categorical
          baseline covariates or outpoints of a continuous
          variable. Under the <ENAMEX TYPE="GPE">MAR</ENAMEX> assumption, the probability of
          missing depends on 
          Z and 
          S but not 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> , namely,
          
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          R = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          z, <ENAMEX TYPE="GPE">s</ENAMEX>, <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>) = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          R = <NUMEX TYPE="CARDINAL">1</NUMEX> | 
          z, s ). (<ENAMEX TYPE="CONTACT_INFO">1</ENAMEX>)
          Because 
          R and 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> are conditionally independent
          given 
          Z and 
          <ENAMEX TYPE="ORGANIZATION">S</ENAMEX> , it follows from (<ENAMEX TYPE="CONTACT_INFO">1</ENAMEX>) that
          
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          z, <ENAMEX TYPE="GPE">s</ENAMEX>, <ENAMEX TYPE="NATIONALITY">R</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>) = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          z, s ). (<ENAMEX TYPE="CONTACT_INFO">2</ENAMEX>)
          In other words, under the <ENAMEX TYPE="GPE">MAR</ENAMEX> assumption in (<ENAMEX TYPE="CONTACT_INFO">1</ENAMEX>), the
          probability of adenoma recurrence conditional on
          treatment assignment and baseline covariates is the same
          in all subjects as in subjects not missing outcome. <ENAMEX TYPE="PERSON">Baker</ENAMEX>
          and <ENAMEX TYPE="PERSON">Laird</ENAMEX> [ <ENAMEX TYPE="LAW">6</ENAMEX> ] proved the related result that under <ENAMEX TYPE="ORGANIZATION">MAR</ENAMEX>
          the maximum likelihood estimate of the probability of
          outcome conditional on covariates is the same in all
          subjects as in subjects not missing outcome.
          With binary outcomes, the overall measure of treatment
          effect is typically a difference, a relative risk, or an
          odds ratio. We focus on the difference because it is easy
          to interpret [ <TIMEX TYPE="DATE">15</TIMEX> ] and because it simplifies our
          formulation. Let Î” 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           denote the treatment effect for stratum <ENAMEX TYPE="CONTACT_INFO">5,</ENAMEX>
          namely
          Î” 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">1</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> ) - 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> ). (<ENAMEX TYPE="CONTACT_INFO">3</ENAMEX>)
          By virtue of the randomization 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          S = 
          s | 
          Z = <NUMEX TYPE="CARDINAL">1</NUMEX>) = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          S = 
          s | 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX>) = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          S = 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> ). Therefore we can write the
          overall treatment effect as
          <ENAMEX TYPE="PER_DESC">Î”</ENAMEX> = Î£ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           Î” 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          S = 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> ). (<ENAMEX TYPE="CONTACT_INFO">4</ENAMEX>)
          If the missing-data mechanism is given in (<ENAMEX TYPE="CONTACT_INFO">1</ENAMEX>), then
          from (<ENAMEX TYPE="CONTACT_INFO">2</ENAMEX>), the treatment effect in stratum 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> (<ENAMEX TYPE="CONTACT_INFO">3</ENAMEX>) equals the treatment effect
          in stratum 
          s among <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> with observed
          <ENAMEX TYPE="CONTACT_INFO">outcomes,</ENAMEX>
          Î” 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">1</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, <ENAMEX TYPE="NATIONALITY">R</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>) - 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, <ENAMEX TYPE="NATIONALITY">R</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>). (<ENAMEX TYPE="CONTACT_INFO">5</ENAMEX>)
          Let 
          <ENAMEX TYPE="ORGANIZATION">n</ENAMEX> 
          
            zsy 
           denote the number of subjects in treatment group 
          z and stratum 
          s who have 
          observed outcome 
          <ENAMEX TYPE="ORGANIZATION">y</ENAMEX> . Based on (<ENAMEX TYPE="CONTACT_INFO">5</ENAMEX>), we estimate Î” 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           by
          
          d 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           = 
          q 
          
          <ENAMEX TYPE="CONTACT_INFO">s 1 -</ENAMEX> 
          q 
          
          <ENAMEX TYPE="ORGANIZATION">s 0</ENAMEX> , where 
          q 
          
            sz 
           = 
          <ENAMEX TYPE="ORGANIZATION">n</ENAMEX> 
          
          <ENAMEX TYPE="CONTACT_INFO">zs 1 /</ENAMEX> 
          <ENAMEX TYPE="ORGANIZATION">n</ENAMEX> 
          
          <ENAMEX TYPE="ORGANIZATION">zs</ENAMEX> + , (<ENAMEX TYPE="CONTACT_INFO">6</ENAMEX>)
          where "+" denotes summation over the indicated
          <ENAMEX TYPE="ORGANIZATION">subscript</ENAMEX>. Let 
          <ENAMEX TYPE="ORGANIZATION">N</ENAMEX> 
          
            zs 
           denote the number of subjects (with either observed
          or missing outcomes) in treatment group 
          z and stratum 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> . We estimate 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          S = 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> ) by 
          <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           = 
          <ENAMEX TYPE="ORGANIZATION">N</ENAMEX> 
          <ENAMEX TYPE="CONTACT_INFO">+</ENAMEX> 
          <ENAMEX TYPE="CONTACT_INFO">s  /</ENAMEX> 
          <ENAMEX TYPE="ORGANIZATION">N</ENAMEX> 
          ++ , giving an overall estimate of
          treatment effect,
          <ENAMEX TYPE="CONTACT_INFO">= Î£</ENAMEX> 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           
          d 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           
          <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           (<ENAMEX TYPE="CONTACT_INFO">7</ENAMEX>)
          The estimate in (<ENAMEX TYPE="CONTACT_INFO">7</ENAMEX>) is closely related to the estimate
          proposed by <ENAMEX TYPE="ORGANIZATION">Horvitz</ENAMEX> and <ENAMEX TYPE="PERSON">Thompson</ENAMEX> [ <TIMEX TYPE="DATE">16</TIMEX> ] . It is also
          maximum likelihood because it is a function of maximum
          likelihood estimates of the parameters. Using the delta
          method, and noting that = 
          d 
          <NUMEX TYPE="CARDINAL">1</NUMEX> 
          <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
          <NUMEX TYPE="CARDINAL">1</NUMEX> + 
          d 
          <NUMEX TYPE="CARDINAL">2</NUMEX> 
          <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
          <NUMEX TYPE="CARDINAL">2</NUMEX> + .... 
          d 
          
          <ENAMEX TYPE="ORGANIZATION">h</ENAMEX> -1 
          <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
          
          <ENAMEX TYPE="ORGANIZATION">h</ENAMEX> <ENAMEX TYPE="PRODUCT">-1</ENAMEX> + 
          d 
          
            <ENAMEX TYPE="ORGANIZATION">h</ENAMEX> 
           (<ENAMEX TYPE="CONTACT_INFO">1 -</ENAMEX> ), we obtain
          
          where 
          <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
          
            <ENAMEX TYPE="ORGANIZATION">h</ENAMEX> 
           <ENAMEX TYPE="CONTACT_INFO">= 1 - .</ENAMEX>
        
        
          <ENAMEX TYPE="PERSON">Bias</ENAMEX> from an omitted binary covariate
          Suppose that instead of (<ENAMEX TYPE="CONTACT_INFO">1</ENAMEX>), the probability of
          missingness depends on treatment assignment, baseline
          strata, 
          and an unobserved binary covariate 
          x . For our example from the Polyp
          <ENAMEX TYPE="ORGANIZATION">Prevention Trial</ENAMEX>, 
          x could be an unreported indicator
          of a family history of colon <ENAMEX TYPE="DISEASE">cancer</ENAMEX>. Then
          
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          R = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          z, <ENAMEX TYPE="GPE">s</ENAMEX>, x, <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>) = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          R = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          z, <ENAMEX TYPE="GPE">s</ENAMEX>, x ). (<ENAMEX TYPE="CONTACT_INFO">9</ENAMEX>)
          In other words the data would be MAR if 
          x were observed. The <ENAMEX TYPE="PRODUCT_DESC">model</ENAMEX> in (<ENAMEX TYPE="CONTACT_INFO">9</ENAMEX>)
          implies that, when 
          x is not observed, missingness
          depends on outcome and on treatment <ENAMEX TYPE="ORG_DESC">group</ENAMEX> via
          
          We assume that for each level of 
          x within stratum 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> , the treatment effect is the
          same, namely
          Î” 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">1</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, x ) - 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, x )
          = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">1</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, x, <ENAMEX TYPE="NATIONALITY">R</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>) - 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, x, <ENAMEX TYPE="NATIONALITY">R</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>) from (<ENAMEX TYPE="CONTACT_INFO">9</ENAMEX>) (<NUMEX TYPE="MONEY">11</NUMEX>)
          Importantly Î” 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           in (<NUMEX TYPE="MONEY">11</NUMEX>) does not depend on 
          x . Let denote the apparent
          treatment effect in stratum 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> after collapsing over 
          x , namely,
          
          To formalize the relationship between and Î” 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           let
          Î± 
          
            xs 
           = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, x, <ENAMEX TYPE="NATIONALITY">R</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>) (<NUMEX TYPE="MONEY">13</NUMEX>)
          Ïˆ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           <ENAMEX TYPE="CONTACT_INFO">= Î±</ENAMEX> 
          <NUMEX TYPE="CARDINAL">1</NUMEX> 
          <ENAMEX TYPE="CONTACT_INFO">s  - Î±</ENAMEX> 
          <NUMEX TYPE="CARDINAL">0</NUMEX> 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>  (<NUMEX TYPE="MONEY">14</NUMEX>)
          Ï† 
          
            zs 
           = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          X = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          z, <ENAMEX TYPE="GPE">s</ENAMEX>, <ENAMEX TYPE="NATIONALITY">R</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>), (<NUMEX TYPE="MONEY">15</NUMEX>)
          Îµ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           <ENAMEX TYPE="CONTACT_INFO">= Ï†</ENAMEX> 
          <NUMEX TYPE="CARDINAL">1</NUMEX> 
          <ENAMEX TYPE="CONTACT_INFO">s  - Ï†</ENAMEX> 
          <NUMEX TYPE="CARDINAL">0</NUMEX> 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>  . (<NUMEX TYPE="MONEY">16</NUMEX>)
          <ENAMEX TYPE="PERSON">Combining</ENAMEX> (<NUMEX TYPE="MONEY">11</NUMEX>) and (<NUMEX TYPE="MONEY">13</NUMEX>), we can write
          
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">1</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, x, <ENAMEX TYPE="NATIONALITY">R</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>) = Î± 
          
            xs 
           <ENAMEX TYPE="CONTACT_INFO">+ Î”</ENAMEX> 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           . (<NUMEX TYPE="MONEY">17</NUMEX>)
          <ENAMEX TYPE="PERSON">Substituting</ENAMEX> (<NUMEX TYPE="MONEY">13</NUMEX>)-(<NUMEX TYPE="MONEY">17</NUMEX>) into (<NUMEX TYPE="MONEY">12</NUMEX>) gives
          
          For a tabular display of these calculations see Table
          <NUMEX TYPE="CARDINAL">1</NUMEX>. For a graphical depiction based on the <ENAMEX TYPE="ORGANIZATION">BK</ENAMEX>-plot [ <NUMEX TYPE="CARDINAL">17 18</NUMEX>
          ] , see Figure <NUMEX TYPE="CARDINAL">1</NUMEX>.
          From (<NUMEX TYPE="MONEY">18</NUMEX>) the bias from omitting 
          x in stratum 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> is Ïˆ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           Îµ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           . The <NUMEX TYPE="ORDINAL">first</NUMEX> factor
          Ïˆ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, <ENAMEX TYPE="LAW">X</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>, 
          R = <NUMEX TYPE="CARDINAL">1</NUMEX>) - 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, <ENAMEX TYPE="LAW">X</ENAMEX> = <NUMEX TYPE="CARDINAL">0</NUMEX>, 
          R = <NUMEX TYPE="CARDINAL">1</NUMEX>) (<NUMEX TYPE="MONEY">19</NUMEX>)
          is the effect of 
          X on subjects in the control group
          with observed outcomes. By virtue of the <ENAMEX TYPE="GPE">MAR</ENAMEX> assumption
          in (<ENAMEX TYPE="CONTACT_INFO">9</ENAMEX>), we could also write Ïˆ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, <ENAMEX TYPE="LAW">X</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>) - 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          <ENAMEX TYPE="ORGANIZATION">Y</ENAMEX> = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">0,5</NUMEX>, 
          X = <NUMEX TYPE="CARDINAL">0</NUMEX>), which is the effect of <NUMEX TYPE="PERCENT">X</NUMEX> on
          all <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> in the control <ENAMEX TYPE="ORG_DESC">group</ENAMEX>. The <NUMEX TYPE="ORDINAL">second</NUMEX> factor,
          Îµ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          X = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">1</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, Z = <NUMEX TYPE="CARDINAL">1</NUMEX>) - 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          X = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          Z = <NUMEX TYPE="CARDINAL">0</NUMEX>, 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>, <ENAMEX TYPE="NATIONALITY">R</ENAMEX> = <NUMEX TYPE="CARDINAL">1</NUMEX>), (<NUMEX TYPE="MONEY">20</NUMEX>)
          ranges from <NUMEX TYPE="PERCENT">-1</NUMEX> to <NUMEX TYPE="CARDINAL">1</NUMEX> and measures the degree of
          confounding between 
          X and 
          Z among <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> with observed
          <ENAMEX TYPE="PERSON">outcomes</ENAMEX> (i.e. 
          R = <NUMEX TYPE="CARDINAL">1</NUMEX>). If Îµ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           <ENAMEX TYPE="CONTACT_INFO">= 0</ENAMEX>, there is no confounding and no bias because the
          distribution of 
          X among <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> with observed
          <ENAMEX TYPE="PERSON">outcomes</ENAMEX> is the same in the control and study <ENAMEX TYPE="ORG_DESC">group</ENAMEX>. If Îµ
          
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           <ENAMEX TYPE="CONTACT_INFO">= Â± 1</ENAMEX> there is complete confounding and the bias
          reaches the maximum value of Â± Ïˆ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           . Taking a weighted average over all strata, the
          overall apparent treatment effect is
          
          and the overall bias is
          
          <ENAMEX TYPE="PERSON">bias = Î</ENAMEX>£ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           Ïˆ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           Îµ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           
          <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           . (<NUMEX TYPE="MONEY">22</NUMEX>)
          Remarkably it is possible to obtain simple bounds on Îµ
          
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           based only on the proportion of <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> who are
          missing in each randomized <ENAMEX TYPE="ORG_DESC">group</ENAMEX> in stratum 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> . Let
          Ï€ 
          
            zs 
           = 
          <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
          R = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
          z, s ) (<NUMEX TYPE="MONEY">23</NUMEX>)
          denote the proportion of subjects in randomization
          <ENAMEX TYPE="ORGANIZATION">group</ENAMEX> 
          z and stratum 
          s with an observed outcome. As
          derived in the <ENAMEX TYPE="ORGANIZATION">Appendix See</ENAMEX> additional file: <ENAMEX TYPE="CONTACT_INFO">1</ENAMEX>, the
          maximum Îµ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           , which we call the upper bound factor, is
          
          If only <NUMEX TYPE="PERCENT">15%</NUMEX> of the <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> are missing in each <ENAMEX TYPE="ORG_DESC">arm</ENAMEX> Îµ 
          ( 
          <ENAMEX TYPE="PERSON">max</ENAMEX> ) 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>  is less than <NUMEX TYPE="CARDINAL">.18</NUMEX>. If we let
          Ïˆ 
          
            <ENAMEX TYPE="PERSON">max</ENAMEX> 
           denote the anticipated maximum value of Ïˆ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           , then substituting (<NUMEX TYPE="MONEY">24</NUMEX>) into (<NUMEX TYPE="MONEY">22</NUMEX>) gives the
          anticipated maximum bias,
          
          <ENAMEX TYPE="PERSON">bias</ENAMEX> 
          
            <ENAMEX TYPE="PERSON">max</ENAMEX> 
           <ENAMEX TYPE="CONTACT_INFO">= Â± Ïˆ</ENAMEX> 
          
            <ENAMEX TYPE="PERSON">max</ENAMEX> 
           Î£ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           Îµ 
          ( 
          <ENAMEX TYPE="PERSON">max</ENAMEX> ) 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>  
          <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           , (<NUMEX TYPE="MONEY">25</NUMEX>)
          where the anticipated maximum bias under complete
          confounding, Ïˆ 
          
            <ENAMEX TYPE="PERSON">max</ENAMEX> 
           , is specified by the <ENAMEX TYPE="PER_DESC">investigator</ENAMEX>; the upper bound
          factor, Îµ 
          ( 
          <ENAMEX TYPE="PERSON">max</ENAMEX> ) 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>  , is based on the fraction
          with observed outcomes in stratum 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> ; and 
          <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           is the fraction of subjects in stratum 
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> .
          Thus the <ENAMEX TYPE="PER_DESC">investigator</ENAMEX> need only specify Ïˆ 
          
            <ENAMEX TYPE="PERSON">max</ENAMEX> 
           . One might argue that if 
          x were a strong unobserved
          inherited gene, Ïˆ 
          
            <ENAMEX TYPE="PERSON">max</ENAMEX> 
           would be close to <NUMEX TYPE="CARDINAL">1</NUMEX>. However because, "eligible
          <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> had no history of <ENAMEX TYPE="DISEASE">colorectal cancer</ENAMEX>, surgical
          resection of adenomas, bowel resection, the polyposis
          <ENAMEX TYPE="DISEASE">syndrome</ENAMEX>, or inflammatory bowel disease" [ <TIMEX TYPE="DATE">14</TIMEX> ] , it is
          unlikely that many subjects had an unobserved
          high-penetrance gene related to the recurrence of
          <ENAMEX TYPE="ORGANIZATION">adenomas</ENAMEX>. We therefore believe that unobserved factors
          that might affect both adenoma recurrence and missingness
          could have an effect of similar magnitude as observed
          baseline covariates. Thus to obtain a plausible value for
          Ïˆ 
          
            <ENAMEX TYPE="PERSON">max</ENAMEX> 
           , we suggest estimating Ïˆ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           , as defined in (<NUMEX TYPE="MONEY">19</NUMEX>), based on observed covariates.
          (See the Results section.) Of course the relationship
          between observed covariates and missingness could differ
          substantially from the relationship between an unobserved
          <ENAMEX TYPE="ORGANIZATION">covariate</ENAMEX> and missingness. Nevertheless, we believe that
          estimates of Ïˆ 
          
            <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
           from observed covariates are helpful for specifying
          a realistic value for Ïˆ 
          
            <ENAMEX TYPE="PERSON">max</ENAMEX> 
           .
          Additional file 1
          
          
          Click here for file
        
      
      
        Results
        We applied our approach to data from the <ENAMEX TYPE="ORGANIZATION">PPT</ENAMEX> trial
        stratified by age and sex (<ENAMEX TYPE="PRODUCT">Table 2</ENAMEX>). We first assumed MAR
        and applied (<ENAMEX TYPE="CONTACT_INFO">7</ENAMEX>) and (<ENAMEX TYPE="CONTACT_INFO">8</ENAMEX>) to estimate the difference in the
        probabilities of adenoma recurrence between the <NUMEX TYPE="CARDINAL">two</NUMEX> <ENAMEX TYPE="ORG_DESC">groups</ENAMEX>.
        We obtained = -<NUMEX TYPE="CARDINAL">.003</NUMEX> with 
        <ENAMEX TYPE="PRODUCT">se</ENAMEX> ( ).=<NUMEX TYPE="CARDINAL">.022</NUMEX>, which is close to the
        <ENAMEX TYPE="ORGANIZATION">unstratified</ENAMEX> estimate and its standard error.
        To compute the anticipated maximum bias (<NUMEX TYPE="MONEY">25</NUMEX>) we first
        computed Îµ 
        ( 
        <ENAMEX TYPE="PERSON">max</ENAMEX> ) 
        s  using (<NUMEX TYPE="MONEY">24</NUMEX>) and estimated 
        <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
        
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
         from the observed fractions (<ENAMEX TYPE="PRODUCT">Table 2</ENAMEX>). This gave Î£ 
        
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
         Îµ 
        ( 
        <ENAMEX TYPE="PERSON">max</ENAMEX> ) 
        <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>  
        <ENAMEX TYPE="ORGANIZATION">w</ENAMEX> 
        
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
         = <NUMEX TYPE="CARDINAL">.10</NUMEX>. We then specified Ïˆ 
        
          <ENAMEX TYPE="PERSON">max</ENAMEX> 
         , the anticipated maximum bias under complete
        <ENAMEX TYPE="ORGANIZATION">confounding</ENAMEX>. To obtain a plausible value for Ïˆ 
        
          <ENAMEX TYPE="PERSON">max</ENAMEX> 
         , we estimated Ïˆ 
        
          <ENAMEX TYPE="ORGANIZATION">s</ENAMEX> 
         in (<NUMEX TYPE="MONEY">19</NUMEX>) pretending either sex or age was the
        unobserved covariate 
        x . This gave = <NUMEX TYPE="CARDINAL">.23</NUMEX>, <NUMEX TYPE="CARDINAL">.18</NUMEX>, <NUMEX TYPE="CARDINAL">.18</NUMEX>, <NUMEX TYPE="CARDINAL">.19</NUMEX>,
        for <TIMEX TYPE="DATE">the four age</TIMEX> categories when 
        x = sex and <NUMEX TYPE="MONEY">.07 and .09</NUMEX> for the two
        sex categories when 
        x = age. Treating the largest as a
        realistic lower bound for Ïˆ 
        
          <ENAMEX TYPE="PERSON">max</ENAMEX> 
         , we specified a slightly larger value, Ïˆ 
        
          <ENAMEX TYPE="PERSON">max</ENAMEX> 
         = <NUMEX TYPE="CARDINAL">.25</NUMEX>, so that the anticipated maximum bias is 
        <ENAMEX TYPE="PERSON">bias</ENAMEX> 
        
          <ENAMEX TYPE="PERSON">max</ENAMEX> 
         = <NUMEX TYPE="MONEY">Â± .25 Ã— .10</NUMEX> = <NUMEX TYPE="CARDINAL">.025</NUMEX>. The <ENAMEX TYPE="ORGANIZATION">MAR</ENAMEX> confidence interval is
        shifted to the right or left by the anticipated maximum
        <ENAMEX TYPE="PERSON">bias</ENAMEX> (Figure <NUMEX TYPE="CARDINAL">2</NUMEX>).
        For purpose of comparison, we also computed estimates
        and confidence intervals under a worst (best) case
        <ENAMEX TYPE="ORGANIZATION">imputation</ENAMEX> [ <ENAMEX TYPE="LAW">9 19</ENAMEX> ] , where missing outcome data in each
        stratum were imputed as no recurrence (recurrence) in
        controls and recurrence (no recurrence) in the intervention
        <ENAMEX TYPE="ORGANIZATION">group</ENAMEX>. (These stratum-specific estimates were combined over
        <ENAMEX TYPE="ORGANIZATION">strata</ENAMEX> using weights inversely proportional to the
        stratum-specific variances.) In the worst and best case
        imputations the confidence intervals did not overlap zero
        (Figure <NUMEX TYPE="CARDINAL">2</NUMEX>).
        Our sensitivity analysis showed that the worst and best
        case imputations were too extreme. Because the absolute
        value of the anticipated maximum bias, <NUMEX TYPE="CARDINAL">.025</NUMEX>, is smaller
        than <NUMEX TYPE="CARDINAL">1.96</NUMEX> Ã— 
        <ENAMEX TYPE="PRODUCT">se</ENAMEX> ( ) = <NUMEX TYPE="CARDINAL">.043</NUMEX>, the bias-adjusted
        confidence intervals overlap <NUMEX TYPE="CARDINAL">zero</NUMEX>. Thus the anticipated
        maximum bias of <NUMEX TYPE="MONEY">Â± .025</NUMEX> did not change our conclusion of
        little evidence of an effect of treatment on adenoma
        recurrence. However it did increase our uncertainty, as the
        more extreme lower and upper bounds indicated that the true
        effect of treatment could likely be higher or lower than
        indicated by the original analysis.
      
      
        Discussion
        The key idea of our method is to incorporate non-<ENAMEX TYPE="GPE">MAR</ENAMEX>
        missingness by postulating an unobserved binary covariate.
        Although similar in spirit to using an unobserved binary
        covariate with observational data [ <TIMEX TYPE="DATE">20</TIMEX> ] , randomization
        adds important extra information that can be usefully
        exploited. Our formulation implies that the probability of
        missingness depends on both outcome and treatment
        assignment.
        The proposed methods hinges on first selecting the
        appropriate baseline covariates. We agree with <ENAMEX TYPE="PERSON">Myers</ENAMEX> [ <TIMEX TYPE="DATE">21</TIMEX> ]
        that if one anticipates missing data, one should collect
        information on the baseline covariates related to outcome
        that might predict missing in outcome. We assumed that
        within a stratum, the effect of treatment did not depend on
        the unobserved binary covariate. We view this as a main
        effect and thus a reasonable approximation.
        We also agree with <ENAMEX TYPE="ORGANIZATION">Shih</ENAMEX> [ <ENAMEX TYPE="LAW">1</ENAMEX> ] that one should collect
        information on the cause of missingness. In particular we
        recommend reporting whether any of the missing outcomes
        were definitely <ENAMEX TYPE="GPE">MAR</ENAMEX>, for example, due to random technical
        problems, to accidents, or to leaving the study for reasons
        completely unrelated to the investigation. Suppose that
        outcome was definitely MAR in a proportion 
        v 
        
          zs 
         of <ENAMEX TYPE="PER_DESC">subjects</ENAMEX>. Then it is more informative to write 
        v 
        
          zs 
         as 
        <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
        R = <NUMEX TYPE="CARDINAL">1</NUMEX>, not MAR| 
        z, s ) + 
        v 
        
          zs 
         . Because 
        v 
        
          zs 
         contains no information about the effect of 
        X on missingness, one can replace Ï€ 
        
          zs 
         by Ï€ 
        
          zs 
         - 
        v 
        
          zs 
         , which reduces Îµ 
        ( 
        <ENAMEX TYPE="PERSON">max</ENAMEX> ) 
        <ENAMEX TYPE="ORGANIZATION">s</ENAMEX>  and hence reduces the
        anticipated maximum bias.
        Although we applied our methodology to a
        <ENAMEX TYPE="ORGANIZATION">cross</ENAMEX>-classification of categorical covariates, it could
        also be applied to continuous covariates or a univariate
        combination of covariates in a manner analogous to a
        propensity score [ <TIMEX TYPE="DATE">22</TIMEX> ] . Let 
        <ENAMEX TYPE="ORGANIZATION">u</ENAMEX> denote a vector of covariates and 
        e 
        
          z 
         = 
        <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
        R = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
        z, <ENAMEX TYPE="ORGANIZATION">u</ENAMEX> ). Following the derivation of
        propensity scores [ <TIMEX TYPE="DATE">22</TIMEX> ] , we can write, 
        <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
        R = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
        z, e 
        
          z 
         ) = 
        E ( 
        r | 
        z, e 
        
          z 
         ) = 
        E ( 
        E ( 
        r | 
        z, <ENAMEX TYPE="ORGANIZATION">u</ENAMEX> )| 
        z, e 
        
          z 
         ) = 
        E ( 
        e 
        
          z 
         | 
        z, e 
        
          z 
         ) = 
        e 
        
          z 
         . Therefore 
        <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
        R = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
        z, <ENAMEX TYPE="ORGANIZATION">u</ENAMEX> ) = 
        <ENAMEX TYPE="ORGANIZATION">pr</ENAMEX> ( 
        R = <NUMEX TYPE="CARDINAL">1|</NUMEX> 
        z, e 
        
          z 
         ), and thus e 
        
          z 
         contains the same information for the probability of
        being observed as 
        <ENAMEX TYPE="ORGANIZATION">u</ENAMEX> . This calculation justifies using 
        e 
        
          z 
         to summarize the covariates predicting missingness. To
        form <NUMEX TYPE="CARDINAL">five</NUMEX> strata for randomized group 
        z , we would compute 
        e 
        
          z 
         for each subject in group 
        z and then divide the distribution of
        
        e 
        
          z 
         into quintiles.
      
      
        Conclusion
        The bias due to an unobserved binary covariate could
        arise when the probability of missingness depends on both
        treatment and outcome. Computation of the bias is easy
        because it equals the maximum anticipated bias under
        complete confounding multiplied by an upper bound factor.
        The maximum anticipated bias might require some expert
        input but some lower bound values can be obtained using
        observed baseline covariate. The upper bound factor is
        easily computed from the fraction missing in each <ENAMEX TYPE="ORG_DESC">group</ENAMEX>.
        The methodology is particularly useful in the common
        situation when <NUMEX TYPE="PERCENT">no more than 15%</NUMEX> of the <ENAMEX TYPE="PER_DESC">subjects</ENAMEX> (in excess
        of those definitely <ENAMEX TYPE="GPE">MAR</ENAMEX>) have missing outcomes, so that the
        upper bound factor in the bias is less than <NUMEX TYPE="CARDINAL">.18</NUMEX>.
      
      
        Contributions
        SGB devised the basic model with the unobserved
        covariate, worked out the unconstrained maximization, and
        wrote the initial draft of the manuscript. <ENAMEX TYPE="ORGANIZATION">LSF</ENAMEX> worked out
        the constrained maximization and provided substantive
        improvements to the manuscript.
      
    
  
